Pfizer Inc. (PFE) Paid $896 Million in Prempro Accords, Filing Shows  
6/19/2012 8:11:20 AM

Pfizer Inc. (PFE) (PFE) has paid $896 million to resolve about 60 percent of the cases alleging its menopause drugs caused cancer in women, the drugmaker said in a securities filing. Pfizer, the world’s largest drugmaker (PFE), has now settled about 6,000 lawsuits alleging Prempro and other hormone- replacement drugs caused breast cancer and has set aside an additional $330 million to resolve the remaining 4,000 suits, according to a filing with the U.S. Securities and Exchange Commission.